Literature DB >> 7056270

Systolic time intervals during spironolactone treatment of digitalized and non-digitalized patients with ischaemic heart disease.

S Waldorff, J Berning, J Buch, E Steiness.   

Abstract

The effect of spironolactone on cardiac contractility indices was studied by externally recording systolic time intervals in four digitalized and four non-digitalized patients with ischaemic heart disease. A negative inotropic effect was found after spironolactone 100mg b.i.d. in all eight patients, as measured by an increase in pre-ejection period index PEPI (p less than 0.01), and the ratio between pre-ejection period and left ventricular ejection time PEP/LVET (p less than 0.001), while pre- and afterload remained constant. As expected, digoxin exerted a positive inotropic effect, as a decrease was observed in PEPI (p less than 0.01), and PEP/LVET (p less than 0.001). It was not possible to ascertain whether the observed effect was caused by a pharmacological interaction at receptor level between spironolactone and digoxin, or indirectly to changes in endogenous substances e.g. aldosterone. The results suggest that spironolactone may have unintended side effects in patients with severe heart failure and that its use be reevaluated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7056270     DOI: 10.1007/bf00637612

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

1.  [Influence of canrenoate potassium (aldactone pro injections) on hemodynamics and myocardial ischemia in experimental myocardial infarct].

Authors:  V Kötter; E v Leitner; G Arbeiter; R Cordes; R Schröder
Journal:  Z Kardiol       Date:  1975-07

2.  Interaction of spironolactone and digoxin in dogs.

Authors:  G E Musgrave; C K Born; C P Davidson; M E Hamrick
Journal:  J Pharmacol Exp Ther       Date:  1977-09       Impact factor: 4.030

3.  Electrophysiologic effects of potassium canrenoate on ouabain-induced ventricular dysrhythmias in rabbits.

Authors:  G Csapo; Y J Sohn; B K Yeh
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

4.  Effect of potassium canrenoate on cardiac functions and (Na + + K + )-activated ATPase.

Authors:  S I Baskin; T Akera; C R Puckett; S L Brody; T M Brody
Journal:  Proc Soc Exp Biol Med       Date:  1973-06

5.  Renal tubular secretion of digoxin.

Authors:  E Steiness
Journal:  Circulation       Date:  1974-07       Impact factor: 29.690

6.  Pharmacokinetics of spironolactone, canrenone and canrenoate-K in humans.

Authors:  W Sadée; M Dagcioglu; R Schröder
Journal:  J Pharmacol Exp Ther       Date:  1973-06       Impact factor: 4.030

7.  [Positive-inotropic heart effect of aldadiene-potassium (Aldactone pro injections)].

Authors:  R Schröder; K P Schüren; G Biamino; V Meyer; W Sadée
Journal:  Klin Wochenschr       Date:  1971-10-01

8.  Correlation between changes in systolic time intervals and left ventricular end-diastolic diameter after preload reduction. Non-invasive monitoring of pharmacological intervention.

Authors:  J Buch; H Egeblad; P B Hansen; H Kjaergård; S Waldorff; E Steiness
Journal:  Br Heart J       Date:  1980-12

9.  Spironolactone-induced changes in digoxin kinetics.

Authors:  S Waldorff; J D Andersen; N Heebøll-Nielsen; O G Nielsen; E Moltke; U Sørensen; E Steiness
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

10.  Canrenoate--a spironolactone metabolite. Acute cardiac effects in digitalized patients.

Authors:  S Waldorff; J Buch
Journal:  Eur J Cardiol       Date:  1979-08
View more
  5 in total

Review 1.  Pharmacokinetic interactions with digoxin.

Authors:  S M Rodin; B F Johnson
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

2.  The acute effects of amiloride and potassium canrenoate on digoxin-induced positive inotropism in healthy volunteers.

Authors:  J P Richter; D K Sommers; J R Snyman; S M Millard
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Amiloride improves hemodynamics in patients with chronic congestive heart failure treated with chronic digoxin and diuretics.

Authors:  M D Cheitlin; R Byrd; N Benowitz; E Liu; G Modin
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

Review 4.  Cardiac glycosides. Drug interactions of clinical significance.

Authors:  B Magnani; P L Malini
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

5.  Negative inotropic effects of aldosterone antagonists in isolated human and guinea-pig ventricular heart muscle.

Authors:  A Mügge; W Schmitz; H Scholz
Journal:  Klin Wochenschr       Date:  1984-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.